Yu Shan
Gründer bei SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Vermögen: 66 Mio $ am 30.04.2024
Aktive Positionen von Yu Shan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Direktor/Vorstandsmitglied | 21.04.1998 | - |
| Vorstandsvorsitzender | 21.04.1998 | - | |
| Gründer | 21.04.1998 | - | |
| Urumqi Shuidishichuan Equity Investment Partnership LP | Corporate Officer/Principal | - | - |
| Direktor/Vorstandsmitglied | - | - | |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
 Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Direktor/Vorstandsmitglied | - | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Direktor/Vorstandsmitglied | 13.01.2014 | - |
Karriereverlauf von Yu Shan
Ausbildung von Yu Shan
| Peking University | Undergraduate Degree |
Statistik
International
| China | 6 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Urumqi Shuidishichuan Equity Investment Partnership LP | |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
